Us Physicalrapy Stock Today
| USPH Stock | USD 89.02 0.47 0.53% |
Performance5 of 100
| Odds Of DistressLess than 6
|
US Physicalrapy is trading at 89.02 as of the 30th of January 2025. This is a 0.53 percent increase since the beginning of the trading day. The stock's open price was 88.55. US Physicalrapy has only a 6 % chance of going through financial distress over the next few years but had a somewhat modest performance during the last 90 days. Note, on November 7, 2024, Representative Josh Gottheimer of US Congress acquired under $15k worth of US Physicalrapy's common stock.
Business Domain Health Care Equipment & Services | IPO Date 28th of May 1992 | Category Healthcare | Classification Health Care |
Physical Therapy, Inc., through its subsidiaries, operates outpatient physical therapy clinics that provide pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries. The company has 15.1 M outstanding shares of which 513.9 K shares are at this time shorted by private and institutional investors with about 5.28 trading days to cover. More on US Physicalrapy
Moving together with USPH Stock
Moving against USPH Stock
USPH Stock Highlights
ESG Sustainability
Environmental | Governance | Social |
| CEO | Christopher Reading | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Business Concentration | Health Care Providers & Services, Health Care Equipment & Services, Health Care, NYSE Composite, SP Small-Cap 600, Health Care, Health Care Providers & Services, Medical Care Facilities, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Average Analyst Recommendation | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial Strength
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt LevelsUS Physicalrapy can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand US Physicalrapy's financial leverage. It provides some insight into what part of US Physicalrapy's total assets is financed by creditors.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
US Physicalrapy (USPH) is traded on New York Stock Exchange in USA. It is located in 1300 West Sam Houston Parkway South, Houston, TX, United States, 77042 and employs 3,899 people. US Physicalrapy is listed under Health Care Providers & Services category by Fama And French industry classification. The company currently falls under 'Mid-Cap' category with a current market capitalization of 1.34 B. US Physicalrapy conducts business under Health Care Providers & Services sector and is part of Health Care industry. The entity has 15.1 M outstanding shares of which 513.9 K shares are at this time shorted by private and institutional investors with about 5.28 trading days to cover.
US Physicalrapy currently holds about 48.57 M in cash with 81.98 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.73.
Check US Physicalrapy Probability Of Bankruptcy
Ownership AllocationThe majority of US Physicalrapy outstanding shares are owned by institutions. These other corporate entities are usually referred to as non-private investors looking to take positions in US Physicalrapy to benefit from reduced commissions. Therefore, outside corporations are subject to a different set of regulations than regular investors in US Physicalrapy. Please pay attention to any change in the institutional holdings of US Physicalrapy as this could imply that something significant has changed or is about to change at the company. On November 7, 2024, Representative Josh Gottheimer of US Congress acquired under $15k worth of US Physicalrapy's common stock.
Check USPH Ownership Details
USPH Stock Institutional Holders
| Instituion | Recorded On | Shares | |
| Gw&k Investment Management, Llc | 2024-09-30 | 320 K | |
| Riverbridge Partners Llc | 2024-12-31 | 310.2 K | |
| Envestnet Asset Management Inc | 2024-09-30 | 249.6 K | |
| Northern Trust Corp | 2024-09-30 | 229.8 K | |
| Fred Alger Management, Llc | 2024-09-30 | 172.3 K | |
| Fmr Inc | 2024-09-30 | 164.5 K | |
| Rockefeller Capital Management L.p. | 2024-09-30 | 160.4 K | |
| Bank Of America Corp | 2024-09-30 | 156.6 K | |
| Silvercrest Asset Management Group Llc | 2024-09-30 | 151.6 K | |
| Blackrock Inc | 2024-09-30 | 2.3 M | |
| Morgan Stanley - Brokerage Accounts | 2024-09-30 | 1.2 M |
US Physicalrapy Historical Income Statement
USPH Stock Against Markets
US Physicalrapy Corporate Directors
| Mark Brookner | Independent Director | Profile | |
| Kathleen Gilmartin | Independent Director | Profile | |
| Clayton Trier | Independent Director | Profile | |
| Bernard Harris | Independent Director | Profile |
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in US Physicalrapy. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey. For more detail on how to invest in USPH Stock please use our How to Invest in US Physicalrapy guide.You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of US Physicalrapy. If investors know USPH will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about US Physicalrapy listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.24) | Dividend Share 1.75 | Earnings Share 0.88 | Revenue Per Share | Quarterly Revenue Growth 0.12 |
The market value of US Physicalrapy is measured differently than its book value, which is the value of USPH that is recorded on the company's balance sheet. Investors also form their own opinion of US Physicalrapy's value that differs from its market value or its book value, called intrinsic value, which is US Physicalrapy's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because US Physicalrapy's market value can be influenced by many factors that don't directly affect US Physicalrapy's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between US Physicalrapy's value and its price as these two are different measures arrived at by different means. Investors typically determine if US Physicalrapy is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, US Physicalrapy's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.